FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a formulation and a pharmaceutical composition for providing more effective transdermal delivery of alkaloids containing alkaloid having a basic nitrile group and a mixture of mono-tocopheryl phosphate and di-tocopheryl phosphate. The invention also refers to using alkaloid having the basic nitrile group and a method for providing more effective transdermal delivery of alkaloid.
EFFECT: providing more effective transdermal delivery of alkaloid.
5 cl, 5 tbl, 6 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
TRANSPORTING FILLER, WHICH CONTAINS ONE OR MORE DI- AND/OR MONO-(ELECTRONIC TRANSMITTING AGENT) PHOSPHATE DERIVATIVES OR THEIR COMPOUNDS | 2006 |
|
RU2434643C2 |
CARRIER VEHICLE FOR ENTERAL APPLICATION | 2005 |
|
RU2377019C2 |
COMPOSITIONS WHICH POISSESS LIPID-REDUCING PROPERTIES | 2006 |
|
RU2428973C2 |
COMPOSITIONS POSSESSING ANTI-CANCIROGENIC PROPERTIES | 2006 |
|
RU2435580C2 |
CARRIER COMPOSITION | 2010 |
|
RU2577233C2 |
ABSORPTION ENHANCERS FOR PHARMACEUTICAL COMPOSITIONS FOR TOPICAL USE | 1994 |
|
RU2165265C2 |
TRANSDERMAL PLASTER | 2011 |
|
RU2553350C2 |
APPLICATION OF METHYL NALTREXONE FOR TREATING IRRITABLE COLON SYNDROME | 2004 |
|
RU2373936C2 |
MEDICAL COMPOSITION FOR PERCUTANEOUS ABSORBTION, PRODUCT KEEPING MEDICAL COMPOSITION, AND PREPARATION FOR PERCUTANEOUS ABSORBTION CONTAINING IT | 2008 |
|
RU2428186C2 |
SYNTHETIC ANALGESIC MEANS OF PEPTIDE NATURE AND METHOD OF ITS USE | 2017 |
|
RU2656188C1 |
Authors
Dates
2013-03-10—Published
2005-03-03—Filed